drugset / Trial / NCT03179761

High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients

NCT03179761

Phase 2 Completed 124 enrolled Vanderbilt-Ingram Cancer Center
RandomizedParallel-groupDouble-blindPrevention

Summary

This randomized phase II studies the side effects of high-dose trivalent influenza vaccine or standard-dose quadrivalent inactivated influenza and how well they work in treating adult patients undergoing stem cell transplant. Season influenza can cause more severe infections in patients who have had a stem cell transplant since their immune system doesn't work as well. Influenza vaccine may provide better protection against flu in adults.

Timeline

Start
2017-10-09
Primary completion
2022-02-15
Completion
2024-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intramuscular